The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127111851 12711185 1 I 20160624 20160823 20160902 20160902 EXP FR-009507513-1608FRA012186 MERCK 73.33 YR M Y 0.00000 20160902 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127111851 12711185 1 PS ISENTRESS RALTEGRAVIR POTASSIUM 1 Oral 1 DF, QD 22145 1 DF TABLET QD
127111851 12711185 2 SS FOSFOCINE FOSFOMYCIN 1 Intravenous (not otherwise specified) 4 G, ONCE IN 8 HOURS 348 G 0 4 G POWDER FOR INJECTION Q8H
127111851 12711185 3 SS CEFAZOLINE PANPHARMA CEFAZOLIN SODIUM 1 Intravenous (not otherwise specified) 6 G, QD 0 6 G QD
127111851 12711185 4 SS TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Oral 1 DF, QD 0 1 DF FILM-COATED TABLET QD
127111851 12711185 5 C DALACINE CLINDAMYCIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) 600 MG, EVERY 6 HOURS 43200 MG 0 600 MG SOLUTION FOR INJECTION Q6H
127111851 12711185 6 C ATENOLOL. ATENOLOL 1 Oral 50 MG, QD 0 50 MG TABLET QD
127111851 12711185 7 C TRINITRINE NITROGLYCERIN 1 Transdermal 1 DF, QD 0 1 DF QD
127111851 12711185 8 C PRASUGREL HYDROCHLORIDE PRASUGREL HYDROCHLORIDE 1 Oral 10 MG, QD 0 10 MG TABLET QD
127111851 12711185 9 C PERINDOPRIL ERBUMINE. PERINDOPRIL ERBUMINE 1 Oral 4 MG, QD 0 4 MG TABLET QD
127111851 12711185 10 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 Oral 20 MG, QD 0 20 MG TABLET QD
127111851 12711185 11 C PARACETAMOL ACTAVIS ACETAMINOPHEN 1 Oral 1 G, FOUR TIMES A DAT 0 1 G QID
127111851 12711185 12 C INSULIN INSULIN NOS 1 Parenteral 79 IU, QD 0 79 IU QD
127111851 12711185 13 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 850 MG, TID 0 850 MG TID
127111851 12711185 14 C PULMICORT TURBUHALER BUDESONIDE 1 Respiratory (inhalation) 1 DF, BID 0 1 DF BID
127111851 12711185 15 C NATISPRAY NITROGLYCERIN 1 Respiratory (inhalation) 0
127111851 12711185 16 C HYDROXYZINE HYDROCHLORIDE. HYDROXYZINE HYDROCHLORIDE 1 Oral 25 MG, TID 0 25 MG TABLET TID
127111851 12711185 17 C SKENAN MORPHINE SULFATE 1 Oral 1 DF, BID 0 1 DF TABLET BID
127111851 12711185 18 C ACTISKENAN MORPHINE SULFATE 1 Oral 5 MG, FOUR TIMES A DAY 0 5 MG TABLET QID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127111851 12711185 2 Otitis externa bacterial
127111851 12711185 3 Otitis externa bacterial
127111851 12711185 4 HIV infection

Outcome of event

Event ID CASEID OUTC COD
127111851 12711185 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127111851 12711185 Renal tubular disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127111851 12711185 2 20160527 20160624 0
127111851 12711185 3 20160121 0
127111851 12711185 5 20160527 20160613 0